Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
QDEL Quidel Corporation daily Stock Chart
QDEL [NASD]
Quidel Corporation
Healthcare | Diagnostic Substances | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.01 Insider Own1.30% Shs Outstand33.77M Perf Week20.36%
Market Cap1.46B Forward P/E112.53 EPS next Y0.38 Insider Trans-44.76% Shs Float27.67M Perf Month28.81%
Income-0.10M PEG- EPS next Q-0.01 Inst Own90.50% Short Float12.97% Perf Quarter57.41%
Sales214.10M P/S6.80 EPS this Y-136.80% Inst Trans-1.30% Short Ratio8.34 Perf Half Y97.34%
Book/sh6.35 P/B6.79 EPS next Y36.79% ROA0.00% Target Price35.80 Perf Year89.12%
Cash/sh5.18 P/C8.32 EPS next 5Y20.00% ROE0.00% 52W Range18.25 - 45.55 Perf YTD101.21%
Dividend- P/FCF61.41 EPS past 5Y-31.00% ROI-0.60% 52W High-5.38% Beta1.21
Dividend %- Quick Ratio6.50 Sales past 5Y3.90% Gross Margin63.50% 52W Low136.16% ATR1.32
Employees627 Current Ratio7.20 Sales Q/Q-2.00% Oper. Margin7.60% RSI (14)76.26 Volatility4.48% 3.03%
OptionableYes Debt/Eq0.71 EPS Q/Q-46.70% Profit Margin0.00% Rel Volume0.99 Prev Close43.13
ShortableYes LT Debt/Eq0.71 EarningsOct 25 AMC Payout0.00% Avg Volume430.46K Price43.10
Recom2.10 SMA2016.97% SMA5023.59% SMA20066.91% Volume425,327 Change-0.07%
Sep-19-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-17Upgrade William Blair Mkt Perform → Outperform
Jul-18-17Upgrade Canaccord Genuity Hold → Buy $25 → $42
Apr-25-17Reiterated Canaccord Genuity Hold $24 → $24.50
Feb-17-17Initiated CL King Neutral
Dec-16-16Downgrade Piper Jaffray Overweight → Neutral
Jun-13-16Upgrade Raymond James Mkt Perform → Outperform
Feb-18-16Reiterated Barclays Overweight $28 → $22
Feb-09-16Downgrade Canaccord Genuity Buy → Hold $22 → $18
Jan-08-16Reiterated Canaccord Genuity Buy $25 → $22
Dec-14-15Downgrade Raymond James Outperform → Mkt Perform
Sep-02-15Initiated Barclays Overweight $28
Jul-31-13Reiterated Canaccord Genuity Buy $30 → $35
Mar-03-11Downgrade Wedbush Outperform → Neutral $14 → $13
Nov-16-10Initiated Canaccord Genuity Buy $18
May-27-10Upgrade Wedbush Neutral → Outperform $15
Apr-07-10Initiated Wedbush Neutral $15
Sep-30-09Initiated William Blair Mkt Perform
Sep-11-09Reiterated Wedbush Morgan Underperform $11 → $12
Aug-06-09Downgrade Wedbush Morgan Neutral → Underperform $11
Sep-20-17 08:35AM  Quidel Corporation (QDEL) Jumps: Stock Rises 6.5% Zacks
Sep-19-17 12:23PM  Here's Why Quidel Corporation Stock Is Popping Today Motley Fool +6.45%
Sep-18-17 07:00AM  Quidel Announces Revised Agreement for Its Pending Acquisition of Aleres B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers Business Wire +14.24%
Sep-08-17 09:00AM  Quidel to Participate in the CEO Series Conference Call Hosted by Canaccord Genuity Business Wire
Aug-15-17 04:54PM  ETFs with exposure to Quidel Corp. : August 15, 2017 Capital Cube
Aug-13-17 12:46PM  Edited Transcript of QDEL earnings conference call or presentation 24-Apr-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-12-17 03:06AM  Edited Transcript of QDEL earnings conference call or presentation 26-Jul-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-01-17 11:54AM  Quidel Corp. :QDEL-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017 Capital Cube
Jul-31-17 04:10PM  Quidel to Present at the 37th Annual Canaccord Genuity Growth Conference Business Wire
Jul-27-17 01:06AM  Quidel reports 2Q loss Associated Press
Jul-26-17 04:10PM  Quidel Reports Second Quarter 2017 Financial Results Business Wire
Jul-19-17 03:56PM  Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings TheStreet.com
07:00AM  Corporate News Blog - Quidel to Acquire Alere Triage(R) Assets Accesswire
Jul-18-17 05:21PM  Quidel Diversifies With Alere's Triage Assets TheStreet.com +9.50%
02:27PM  Abbott's Tarnished Deal Sparkles for Another Bloomberg
01:04PM  Here's Why Quidel Corporation Is Rising Today Motley Fool
08:20AM  Quidel (QDEL) Worth a Look: Stock Jumps 25.4% in Session Zacks
Jul-17-17 06:00AM  Quidel Announces Definitive Agreement to Acquire Alere Triage® Assets Business Wire +25.35%
Jul-14-17 04:05PM  Quidel to Hold Second Quarter 2017 Financial Results Conference Call on July 26, 2017 Business Wire
Jun-28-17 03:45PM  Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Respiratory Syncytial Virus (RSV) Assay Business Wire
Jun-22-17 06:45PM  Quidels Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards from Good Design Australia®s 2017 Good Design Awards® Business Wire
Jun-07-17 06:00PM  Quidel Receives the CE Mark for Its Thyretain® TBI Reporter BioAssay Business Wire
May-30-17 02:15PM  Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Immunoassay Analyzer for Use with Sofia Influenza A+B Assay Business Wire
May-24-17 06:30PM  Quidel Receives PMDA Approval for Its Point-of-Care Sofia® Influenza A+B Assay Business Wire
May-18-17 01:58PM  ETFs with exposure to Quidel Corp. : May 18, 2017 Capital Cube
May-16-17 05:15PM  Quidel Completes Acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses Marketwired
May-11-17 02:30PM  Quidel Receives FDA Clearance for Its New Solana(R) Molecular Assay for the Detection of Clostridium difficile (C. difficile) Infections Marketwired
May-02-17 04:31PM  ETFs with exposure to Quidel Corp. : May 2, 2017 Capital Cube
May-01-17 05:30PM  Quidel to Present at the Bank of America Merrill Lynch 2017 Health Care Conference Marketwired
11:13AM  Quidel Corp. :QDEL-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 Capital Cube
Apr-26-17 08:31AM  Edited Transcript of QDEL earnings conference call or presentation 24-Apr-17 9:00pm GMT Thomson Reuters StreetEvents
Apr-24-17 05:00PM  Quidel posts 1Q profit Associated Press
04:10PM  Quidel Reports First Quarter 2017 Financial Results Marketwired
Apr-11-17 07:00PM  Quidel to Hold First Quarter 2017 Financial Results Conference Call on April 24, 2017 Marketwired
Apr-07-17 09:37AM  PetMed Faces Concerns over New Order Sales, Competition Zacks
Apr-06-17 08:30AM  Strength Seen in Alere (ALR): Stock Adds 9.4% in Session Zacks
Apr-04-17 09:30AM  Zacks.com featured highlights: Heska, Quidel, Trinseo S.A., Advanced Energy Industries and Pioneer Natural Resources Zacks
Apr-03-17 08:20AM  5 Stocks with Solid Efficiency Ratio to Buy in April Zacks
Mar-24-17 09:30AM  Zacks Industry Outlook Highlights: Quidel, OraSure Technologies, ResMed, Inogen and Masimo Zacks
Mar-22-17 08:25AM  OraSure Technologies (OSUR) In Focus: Stock Jumps 8.4% Zacks
Mar-16-17 09:30AM  The Zacks Analyst Blog Highlights: Health Insurance Innovations, Big 5 Sporting Goods, Quidel, Planet Payment and Bridgepoint Education Zacks
Mar-15-17 01:33PM  Small Caps Back to Breakeven for 2017, Buy These 5 Stocks on the Dip Zacks
08:35AM  Orthofix International (OFIX) Looks Good: Stock Jumps 9.9% Zacks
Mar-13-17 04:19PM  QUIDEL CORP /DE/ Files SEC form 8-K, Regulation FD Disclosure
Mar-02-17 06:00PM  Quidel to Present at the Barclays Global Healthcare Conference Marketwired
Feb-28-17 04:57PM  QUIDEL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
Feb-22-17 01:04PM  QUIDEL CORP /DE/ Financials
Feb-21-17 05:04PM  QUIDEL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-17-17 07:36AM  Coverage initiated on Quidel by CL King
Feb-16-17 05:15PM  QUIDEL CORP /DE/ Files SEC form 10-K, Annual Report
Feb-15-17 11:13AM  Quidel Corp. :QDEL-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017 Capital Cube
Feb-10-17 02:01PM  Quidel Corp. :QDEL-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017
Feb-08-17 09:53PM  Edited Transcript of QDEL earnings conference call or presentation 8-Feb-17 10:00pm GMT
05:18PM  Quidel reports 4Q loss
05:00PM  Quidel Corp Earnings Call scheduled for 5:00 pm ET today
04:18PM  QUIDEL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:10PM  Quidel Reports Fourth Quarter and Full Year 2016 Financial Results Marketwired
07:07AM  Q4 2016 Quidel Corp Earnings Release - After Market Close
Jan-25-17 04:30PM  Quidel to Hold Fourth Quarter and Full Year 2016 Financial Results Conference Call on February 8, 2017 Marketwired
Jan-24-17 06:09AM  QUIDEL CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-23-17 07:00PM  Quidel Announces Modification of Revenue Reporting Categories Marketwired
Jan-06-17 04:18PM  QUIDEL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financi
04:10PM  Quidel Announces Preliminary Revenue for Fourth Quarter 2016 Marketwired
Dec-20-16 04:10PM  Quidel to Present at 35th Annual J.P. Morgan Healthcare Conference Marketwired
10:09AM  Quidel Corp. Value Analysis (NASDAQ:QDEL) : December 20, 2016
Dec-19-16 07:48AM  Quidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : December 19, 2016
Dec-13-16 11:47AM  ETFs with exposure to Quidel Corp. : December 13, 2016
Dec-10-16 09:37PM  Should You Add Corcept Therapeutics Incorporated (CORT) To Your Portfolio? at Insider Monkey
Dec-02-16 04:17PM  QUIDEL CORP /DE/ Files SEC form 8-K, Termination of a Material Definitive Agreement
Nov-30-16 01:00PM  ETFs with exposure to Quidel Corp. : November 30, 2016
Nov-29-16 10:00AM  Quidel Receives FDA Clearance for Its New Solana(R) Molecular Assay for the Detection of Herpes Simplex Virus 1+2 and Varicella Zoster Virus Marketwired
Nov-17-16 04:30PM  Quidel to Present at the 28th Annual Piper Jaffray Healthcare Conference Marketwired
Nov-02-16 02:07PM  ETFs with exposure to Quidel Corp. : November 2, 2016
Oct-31-16 11:24AM  Quidel Corp. :QDEL-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016
Oct-28-16 06:03AM  QUIDEL CORP /DE/ Files SEC form 10-Q, Quarterly Report -6.36%
Oct-27-16 09:33AM  Thermo Fisher (TMO) Tops Q3 Earnings, Raises '16 Outlook
09:32AM  NuVasive (NUVA) Earnings & Revenues Miss Estimates in Q3
09:30AM  Abaxis (ABAX) Q2 Earnings & Revenues Miss, Margins Slide
09:29AM  Mead Johnson (MJN) Tops Q3 Earnings, Lags Sales, Guides Low
06:51AM  Cardiovascular Systems (CSII) Q1 Loss Lower than Expected
Oct-26-16 11:44PM  Edited Transcript of QDEL earnings conference call or presentation 26-Oct-16 9:00pm GMT
06:33PM  Quidel reports 3Q loss
05:00PM  Quidel Corp Earnings Call scheduled for 5:00 pm ET today
04:21PM  QUIDEL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:10PM  Quidel Reports Third Quarter 2016 Financial Results Marketwired
10:40AM  ResMed (RMD) Misses Earnings & Revenue Estimates in Q1
10:33AM  LabCorp (LH) Q3 Earnings Miss, Revenues in Line; Guides Up
10:15AM  Boston Scientific's (BSX) Q3 Earnings in Line, Guides Up
07:15AM  Edwards Lifesciences (EW) Q3 Earnings in Line, Sales Miss
07:07AM  Q3 2016 Quidel Corp Earnings Release - After Market Close
Oct-25-16 04:10PM  Quidel Receives FDA Clearance for Its New Solana(R) Strep Complete Assay for Rapid and Qualitative Detection and Differentiation of S. pyogenes (Group A Beta-Hemolytic Streptococcus) and S. dysgalactiae (Pyogenic Group C and G Beta-Hemolyti Marketwired
09:01AM  PetMed (PETS) Earnings Miss, Revenues Top Estimates in Q2
08:46AM  Quidel Corp. breached its 50 day moving average in a Bullish Manner : QDEL-US : October 25, 2016
Oct-20-16 04:05PM  Walgreens Boots (WBA) Earnings Top, Margins Slide in Q4
Oct-14-16 08:57AM  Medtronic: FDA OKs MRI Scan-Compatible Cardiac Devices
Oct-13-16 09:39AM  QIAGEN's High-Throughput Solutions for Human ID Database
Oct-12-16 04:30PM  Quidel to Hold Third Quarter 2016 Financial Results Conference Call on October 26, 2016 Marketwired
09:13AM  Myriad Genetics Reports Encouraging myChoice HRD Data
08:44AM  Quidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : October 12, 2016
07:35AM  Teleflex (TFX) Gets FDA Clearance for Arrow & TightTrack
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC women's and general health, and gastrointestinal diseases. The company offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus (RSV), QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S. Pneomoniae fluorescent immunoassay (FIA) to detect pneumococcal pneumonia and meningitis; Sofia Legionella FIA to detect Legionella pneumophila seorgroup 1 antigen; AmpliVue Bordetella assay to detect Bordetella pertussis; and Lyra Adenovirus assay to detect human adenovirus viral DNA. In addition, the company offers Sofia hCG fluorescent immunoassay and QuickVue pregnancy tests to detect hCG in serum or urine; Thyretain for the diagnosis of graves disease; QuickVue Chlamydia test to detect Chlamydia trachomatis; Solana Trichomonas assay for the diagnosis of trichomoniasis; and clinical and research products for the assessment of osteoporosis and evaluation of bone resorption/formation. Further, it provides Lyra Direct C. difficile assay to detect Clostridium difficile Toxin A or Toxin B genes; Super E-Mix and D3 IFA Enterovirus indirect fluorescent antibody products; QuickVue fecal immunochemical test to detect the presence of blood in stool specimens; and serological tests to measure antibodies circulating in the blood. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRYANT DOUGLAS CPresident & CEOAug 31Option Exercise12.3612,000148,320296,493Aug 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOAug 31Sale34.8412,000418,068284,493Aug 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOAug 30Option Exercise12.3612,000148,320296,493Aug 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOAug 30Sale34.5812,000414,912284,493Aug 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOAug 29Option Exercise12.3612,000148,320296,493Aug 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOAug 29Sale33.9212,000407,004284,493Aug 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOJul 31Option Exercise12.3612,000148,320296,493Jul 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOJul 31Sale32.1312,000385,512284,493Jul 31 08:06 PM
STEWARD RANDALL JChief Financial OfficerJul 28Option Exercise16.3294,2151,537,418114,122Aug 01 08:12 PM
BRYANT DOUGLAS CPresident & CEOJul 28Option Exercise12.3612,000148,320296,493Jul 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOJul 28Sale33.5712,000402,828284,493Jul 31 08:06 PM
STEWARD RANDALL JChief Financial OfficerJul 28Sale34.0994,2153,211,93119,907Aug 01 08:12 PM
Abney Michael Donald Jr.SVP - DistributionJul 28Sale33.831,17339,679866Aug 01 08:10 PM
BRYANT DOUGLAS CPresident & CEOJul 27Option Exercise12.3612,000148,320296,493Jul 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOJul 27Sale35.7912,000429,480284,493Jul 31 08:06 PM
BRYANT DOUGLAS CPresident & CEOJun 30Option Exercise12.3612,000148,320296,493Jun 30 07:59 PM
BRYANT DOUGLAS CPresident & CEOJun 30Sale27.2312,000326,760284,493Jun 30 07:59 PM
BRYANT DOUGLAS CPresident & CEOJun 29Option Exercise12.3612,000148,320296,493Jun 30 07:59 PM
BRYANT DOUGLAS CPresident & CEOJun 29Sale27.3312,000327,960284,493Jun 30 07:59 PM
BRYANT DOUGLAS CPresident & CEOJun 28Option Exercise12.3612,000148,320296,493Jun 30 07:59 PM
BRYANT DOUGLAS CPresident & CEOJun 28Sale27.3512,000328,200284,493Jun 30 07:59 PM
BRYANT DOUGLAS CPresident & CEOMay 31Option Exercise12.3612,000148,320296,493May 31 08:02 PM
BRYANT DOUGLAS CPresident & CEOMay 31Sale24.9312,000299,160284,493May 31 08:02 PM
BRYANT DOUGLAS CPresident & CEOMay 30Option Exercise12.3612,000148,320296,493May 31 08:02 PM
BRYANT DOUGLAS CPresident & CEOMay 30Sale25.1012,000301,200284,493May 31 08:02 PM
BRYANT DOUGLAS CPresident & CEOMay 26Option Exercise12.3612,000148,320296,493May 31 08:02 PM
BRYANT DOUGLAS CPresident & CEOMay 26Sale24.9012,000298,800284,493May 31 08:02 PM
WIDDER KENNETH JDirectorMay 17Option Exercise0.0096206,210May 18 08:11 PM
SLACIK CHARLES PDirectorMay 17Option Exercise0.0096202,601May 18 08:10 PM
POLAN MARY LAKE PH DDirectorMay 17Option Exercise0.00962013,012May 18 08:08 PM
BUECHLER KENNETH FDirectorMay 17Option Exercise0.001,263022,418May 18 08:06 PM
POLAN MARY LAKE PH DDirectorMay 14Option Exercise0.001,101010,432May 16 09:43 PM
WIDDER KENNETH JDirectorMay 05Option Exercise0.002,10703,226May 09 08:30 PM
BUECHLER KENNETH FDirectorMay 05Option Exercise0.004,315017,430May 09 08:29 PM
Brown Thomas DDirectorMay 05Option Exercise0.002,631042,041May 09 08:28 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselMay 02Option Exercise12.6310,000126,30047,759May 03 08:18 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselMay 02Sale24.5010,000245,00037,759May 03 08:18 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselMay 01Option Exercise13.2626,225347,71857,759May 03 08:18 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselMay 01Sale24.2033,225803,94837,759May 03 08:18 PM
BRYANT DOUGLAS CPresident & CEOApr 28Option Exercise12.3612,000148,320296,493Apr 28 08:02 PM
BRYANT DOUGLAS CPresident & CEOApr 28Sale24.2012,000290,400284,493Apr 28 08:02 PM
BRYANT DOUGLAS CPresident & CEOApr 27Option Exercise12.3612,000148,320296,493Apr 28 08:02 PM
BRYANT DOUGLAS CPresident & CEOApr 27Sale24.1612,000289,920284,493Apr 28 08:02 PM
BRYANT DOUGLAS CPresident & CEOApr 26Option Exercise12.3612,000148,320296,493Apr 28 08:02 PM
BRYANT DOUGLAS CPresident & CEOApr 26Sale24.1112,000289,320284,493Apr 28 08:02 PM
BRYANT DOUGLAS CPresident & CEOMar 31Option Exercise12.3612,000148,320296,493Mar 31 07:41 PM
BRYANT DOUGLAS CPresident & CEOMar 31Sale22.6912,000272,280284,493Mar 31 07:41 PM
BRYANT DOUGLAS CPresident & CEOMar 30Option Exercise12.3612,000148,320296,493Mar 31 07:41 PM
BRYANT DOUGLAS CPresident & CEOMar 30Sale22.5212,000270,240284,493Mar 31 07:41 PM
BRYANT DOUGLAS CPresident & CEOMar 29Option Exercise12.3613,080161,669297,573Mar 31 07:41 PM
BRYANT DOUGLAS CPresident & CEOMar 29Sale22.3013,080291,684284,493Mar 31 07:41 PM
POLAN MARY LAKE PH DDirectorMar 27Option Exercise13.979,331130,3549,331Mar 29 07:35 PM
BRYANT DOUGLAS CPresident & CEOFeb 28Option Exercise12.3626,920332,731307,226Feb 28 08:46 PM
BRYANT DOUGLAS CPresident & CEOFeb 28Sale21.3026,920573,288280,306Feb 28 08:46 PM
BRYANT DOUGLAS CPresident & CEOFeb 27Option Exercise10.5136,000378,522316,306Feb 28 08:46 PM
BRYANT DOUGLAS CPresident & CEOFeb 27Sale21.8236,000785,340280,306Feb 28 08:46 PM
BRYANT DOUGLAS CPresident & CEOFeb 24Option Exercise8.5044,000374,000322,958Feb 28 08:46 PM
BRYANT DOUGLAS CPresident & CEOFeb 24Sale21.1144,000928,686278,958Feb 28 08:46 PM
Brown Thomas DDirectorFeb 15Option Exercise13.979,331130,35439,410Mar 07 05:36 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselDec 01Option Exercise15.282,71241,43944,608Dec 02 07:40 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselDec 01Sale23.002,71262,37641,896Dec 02 07:40 PM
BRYANT DOUGLAS CPresident & CEONov 30Option Exercise8.5024,000204,000298,011Nov 30 07:39 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselNov 30Option Exercise16.7739,288659,00174,896Dec 02 07:40 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselNov 30Sale22.8357,2881,307,84541,896Dec 02 07:40 PM
BRYANT DOUGLAS CPresident & CEONov 30Sale22.8024,000547,200274,011Nov 30 07:39 PM
BRYANT DOUGLAS CPresident & CEONov 29Option Exercise8.5024,000204,000298,011Nov 30 07:39 PM
BRYANT DOUGLAS CPresident & CEONov 29Sale22.8424,000548,088274,011Nov 30 07:39 PM
BRYANT DOUGLAS CPresident & CEONov 28Option Exercise8.5024,000204,000298,011Nov 30 07:39 PM
BRYANT DOUGLAS CPresident & CEONov 28Sale23.0224,000552,480274,011Nov 30 07:39 PM
TAMERIUS JOHNSVP, Strat & Ext AffairsNov 25Option Exercise16.778,878148,88432,418Nov 29 08:08 PM
TAMERIUS JOHNSVP, Strat & Ext AffairsNov 25Sale23.508,878208,63323,540Nov 29 08:08 PM
BRYANT DOUGLAS CPresident & CEOSep 30Option Exercise8.5035,291299,974309,302Sep 30 08:56 PM
BRYANT DOUGLAS CPresident & CEOSep 30Sale22.0835,291779,225274,011Sep 30 08:56 PM
BRYANT DOUGLAS CPresident & CEOSep 29Option Exercise8.5016,767142,520290,778Sep 30 08:56 PM
BRYANT DOUGLAS CPresident & CEOSep 29Sale21.2216,767355,796274,011Sep 30 08:56 PM
BRYANT DOUGLAS CPresident & CEOSep 28Option Exercise8.5017,110145,435291,121Sep 30 08:56 PM
BRYANT DOUGLAS CPresident & CEOSep 28Sale21.6117,110369,747274,011Sep 30 08:56 PM
open in yahoo | open in reuters | open in google